Typical clinical characters of CDKL5-related disorders (CDD) include infantile-onset refractory epilepsy, hypotonia, developmental delay, intellectual disability, and visual impairment [2–4, 9]. This evidence concerns the gene CDKL5 and Global developmental delay.